Methyl Cinnamate (MC) Alleviates Free Fatty Acids (FFAs) Induced Lipid Accumulation Through the AMPK Pathway in HepG2 Cells

References

• Eslam M, Newsome PN, Sarin SK, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73(1):202–209. doi:10.1016/j.jhep.2020.03.039
   PubMed Web of Science ®Google Scholar
• Loomba R, Friedman SL, Shulman GI. Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell. 2021;184(10):2537–2564. doi:10.1016/j.cell.2021.04.015
   PubMed Web of Science ®Google Scholar
• Moon AM, Singal AG, Tapper EB. Contemporary epidemiology of chronic liver disease and cirrhosis. Clin Gastroenterol Hepatol. 2020;18(12):2650–2666. doi:10.1016/j.cgh.2019.07.060
   PubMed Web of Science ®Google Scholar
• Byrne CD, Targher G. NAFLD: a multisystem disease. J Hepatol. 2015;62(1 Suppl):S47–64. doi:10.1016/j.jhep.2014.12.012
   PubMed Web of Science ®Google Scholar
• Targher G, Byrne CD, Tilg H. NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications. Gut. 2020;69(9):1691–1705. doi:10.1136/gutjnl-2020-320622
   PubMed Web of Science ®Google Scholar
• Mantovani A, Lombardi R, Cattazzo F, Zusi C, Cappelli D, Dalbeni A. MAFLD and CKD: an Updated Narrative Review. Int J Mol Sci. 2022;23(13). doi:10.3390/ijms23137007
   Web of Science ®Google Scholar
• Sun DQ, Jin Y, Wang TY, et al. MAFLD and risk of CKD. Metabolism. 2021;115:154433. doi:10.1016/j.metabol.2020.154433
   PubMed Web of Science ®Google Scholar
• Chen J, Deng X, Liu Y, et al. Kupffer cells in non-alcoholic fatty liver disease: friend or foe? Int J Biol Sci. 2020;16(13):2367–2378. doi:10.7150/ijbs.47143
   PubMed Web of Science ®Google Scholar
• Lee E, Korf H, Vidal-Puig A. An adipocentric perspective on the development and progression of non-alcoholic fatty liver disease. J Hepatol. 2023;78(5):1048–1062. doi:10.1016/j.jhep.2023.01.024
   PubMed Web of Science ®Google Scholar
• Peters KM, Wilson RB, Borradaile NM. Non-parenchymal hepatic cell lipotoxicity and the coordinated progression of non-alcoholic fatty liver disease and atherosclerosis. Curr Opin Lipidol. 2018;29(5):417–422. doi:10.1097/mol.0000000000000535
   PubMed Web of Science ®Google Scholar
• Nassir F. NAFLD: mechanisms, Treatments, and Biomarkers. Biomolecules. 2022;12(6). doi:10.3390/biom12060824
   PubMed Web of Science ®Google Scholar
• Hardie DG, Ross FA, Hawley SA. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol. 2012;13(4):251–262. doi:10.1038/nrm3311
   PubMed Web of Science ®Google Scholar
• Hawley SA, Selbert MA, Goldstein EG, Edelman AM, Carling D, Hardie DG. 5’-AMP activates the AMP-activated protein kinase cascade, and Ca2+/calmodulin activates the calmodulin-dependent protein kinase I cascade, via three independent mechanisms. J Biol Chem. 1995;270(45):27186–27191. doi:10.1074/jbc.270.45.27186
   PubMed Web of Science ®Google Scholar
• Davies SP, Helps NR, Cohen PT, Hardie DG. 5’-AMP inhibits dephosphorylation, as well as promoting phosphorylation, of the AMP-activated protein kinase. Studies using bacterially expressed human protein phosphatase-2C alpha and native bovine protein phosphatase-2AC. FEBS Lett. 1995;377(3):421–425. doi:10.1016/0014-5793(95)01368-7
   PubMed Web of Science ®Google Scholar
• Marcelo KL, Means AR, York B. The Ca(2+)/Calmodulin/CaMKK2 Axis: nature’s Metabolic CaMshaft. Trends Endocrinol Metab. 2016;27(10):706–718. doi:10.1016/j.tem.2016.06.001
   PubMed Web of Science ®Google Scholar
• Hawley SA, Boudeau J, Reid JL, et al. Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. J Biol. 2003;2(4):28. doi:10.1186/1475-4924-2-28
   PubMedGoogle Scholar
• Hardie DG, Carling D. The AMP-activated protein kinase--fuel gauge of the mammalian cell? Eur J Biochem. 1997;246(2):259–273. doi:10.1111/j.1432-1033.1997.00259.x
   PubMedGoogle Scholar
• Batchuluun B, Pinkosky SL, Steinberg GR. Lipogenesis inhibitors: therapeutic opportunities and challenges. Nat Rev Drug Discov. 2022;21(4):283–305. doi:10.1038/s41573-021-00367-2
   PubMed Web of Science ®Google Scholar
• McGarry JD, Brown NF. The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur J Biochem. 1997;244(1):1–14. doi:10.1111/j.1432-1033.1997.00001.x
   PubMedGoogle Scholar
• Monsénégo J, Mansouri A, Akkaoui M, et al. Enhancing liver mitochondrial fatty acid oxidation capacity in obese mice improves insulin sensitivity independently of hepatic steatosis. J Hepatol. 2012;56(3):632–639. doi:10.1016/j.jhep.2011.10.008
   PubMed Web of Science ®Google Scholar
• Li Y, Xu S, Mihaylova MM, et al. AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab. 2011;13(4):376–388. doi:10.1016/j.cmet.2011.03.009
   PubMed Web of Science ®Google Scholar
• El-Mir MY, Nogueira V, Fontaine E, Avéret N, Rigoulet M, Leverve X. Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I. J Biol Chem. 2000;275(1):223–228. doi:10.1074/jbc.275.1.223
   PubMed Web of Science ®Google Scholar
• Nagashimada M, Ota T. Role of vitamin E in nonalcoholic fatty liver disease. IUBMB Life. 2019;71(4):516–522. doi:10.1002/iub.1991
   PubMed Web of Science ®Google Scholar
• Sodum N, Kumar G, Bojja SL, Kumar N, Rao CM. Epigenetics in NAFLD/NASH: targets and therapy. Pharmacol Res. 2021;167:105484. doi:10.1016/j.phrs.2021.105484
   PubMed Web of Science ®Google Scholar
• Feng X, Lin Y, Zhuo S, et al. Treatment of obesity and metabolic-associated fatty liver disease with a diet or orlistat: a randomized controlled trial. Am J Clin Nutr. 2023;117(4):691–700. doi:10.1016/j.ajcnut.2023.02.008
   PubMed Web of Science ®Google Scholar
• Sun W, Liu P, Wang T, Wang X, Zheng W, Li J. Baicalein reduces hepatic fat accumulation by activating AMPK in oleic acid-induced HepG2 cells and high-fat diet-induced non-insulin-resistant mice. Food Funct. 2020;11(1):711–721. doi:10.1039/c9fo02237f
   PubMed Web of Science ®Google Scholar
• Zhu X, Bian H, Wang L, et al. Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway. Free Radic Biol Med. 2019;141:192–204. doi:10.1016/j.freeradbiomed.2019.06.019
   PubMed Web of Science ®Google Scholar
• Bhatia SP, Wellington GA, Cocchiara J, Lalko J, Letizia CS, Api AM. Fragrance material review on methyl cinnamate. Food Chem Toxicol. 2007;45(Suppl 1):S113–119. doi:10.1016/j.fct.2007.09.077
   PubMedGoogle Scholar
• E L, Li W, Hu Y, Deng L, Yao J, Zhou X. Methyl cinnamate protects against dextran sulfate sodium-induced colitis in mice by inhibiting the MAPK signaling pathway. Acta Biochim Biophys Sin. 2023. doi:10.3724/abbs.2023124
   Google Scholar
• Alam F, Saqib QNU, Ashraf M. Zanthoxylum armatum DC extracts from fruit, bark and leaf induce hypolipidemic and hypoglycemic effects in mice- in vivo and in vitro study. BMC Complement Altern Med. 2018;18(1):68. doi:10.1186/s12906-018-2138-4
   PubMedGoogle Scholar
• Chen YY, Lee MH, Hsu CC, Wei CL, Tsai YC. Methyl cinnamate inhibits adipocyte differentiation via activation of the CaMKK2-AMPK pathway in 3T3-L1 preadipocytes. J Agric Food Chem. 2012;60(4):955–963. doi:10.1021/jf203981x
   PubMed Web of Science ®Google Scholar
• Gui Y, Chen L, Duan S, Li G, Tang J, Li A. Methyl cinnamate alleviated CCI-induced upregulation of spinal AMPA receptors and pain hypersensitivity by targeting AMPK. Eur J Pharmacol. 2018;833:183–189. doi:10.1016/j.ejphar.2018.05.033
   PubMed Web of Science ®Google Scholar
• Kim S, Chen J, Cheng T, et al. PubChem 2023 update. Nucleic Acids Res. 2023;51(D1):D1373–d1380. doi:10.1093/nar/gkac956
   PubMed Web of Science ®Google Scholar
• Cokorinos EC, Delmore J, Reyes AR, et al. Activation of Skeletal Muscle AMPK Promotes Glucose Disposal and Glucose Lowering in Non-human Primates and Mice. Cell Metab. 2017;25(5):1147–1159.e1110. doi:10.1016/j.cmet.2017.04.010
   PubMed Web of Science ®Google Scholar
• Xiao B, Sanders MJ, Carmena D, et al. Structural basis of AMPK regulation by small molecule activators. Nat Commun. 2013;4:3017. doi:10.1038/ncomms4017
   PubMed Web of Science ®Google Scholar
• Gómez-Lechón MJ, Donato MT, Martínez-Romero A, Jiménez N, Castell JV, O’Connor JE. A human hepatocellular in vitro model to investigate steatosis. Chem Biol Interact. 2007;165(2):106–116. doi:10.1016/j.cbi.2006.11.004
   PubMed Web of Science ®Google Scholar
• Herzig S, Shaw RJ. AMPK: guardian of metabolism and mitochondrial homeostasis. Nat Rev Mol Cell Biol. 2018;19(2):121–135. doi:10.1038/nrm.2017.95
   PubMed Web of Science ®Google Scholar
• Fang K, Wu F, Chen G, et al. Diosgenin ameliorates palmitic acid-induced lipid accumulation via AMPK/ACC/CPT-1A and SREBP-1c/FAS signaling pathways in LO2 cells. BMC Complement Altern Med. 2019;19(1):255. doi:10.1186/s12906-019-2671-9
   PubMed Web of Science ®Google Scholar
• Yao Q, Li S, Cheng X, Zou Y, Shen Y, Zhang S. Yin Zhi Huang traditional Chinese herbal formula, ameliorates diet-induced obesity and hepatic steatosis by activating the AMPK/SREBP-1 and the AMPK/ACC/CPT1A pathways. Ann Transl Med. 2020;8(5):231. doi:10.21037/atm.2020.01.31
   PubMed Web of Science ®Google Scholar
• Zhang YL, Hernandez-Ono A, Siri P, et al. Aberrant hepatic expression of PPARgamma2 stimulates hepatic lipogenesis in a mouse model of obesity, insulin resistance, dyslipidemia, and hepatic steatosis. J Biol Chem. 2006;281(49):37603–37615. doi:10.1074/jbc.M604709200
   PubMed Web of Science ®Google Scholar
• Gai H, Zhou F, Zhang Y, et al. Coniferaldehyde ameliorates the lipid and glucose metabolism in palmitic acid-induced HepG2 cells via the LKB1/AMPK signaling pathway. J Food Sci. 2020;85(11):4050–4060. doi:10.1111/1750-3841.15482
   PubMed Web of Science ®Google Scholar
• Zhang YL, Guo H, Zhang CS, et al. AMP as a low-energy charge signal autonomously initiates assembly of AXIN-AMPK-LKB1 complex for AMPK activation. Cell Metab. 2013;18(4):546–555. doi:10.1016/j.cmet.2013.09.005
   PubMed Web of Science ®Google Scholar
• Kusmic C, L’Abbate A, Sambuceti G, et al. Improved myocardial perfusion in chronic diabetic mice by the up-regulation of pLKB1 and AMPK signaling. J Cell Biochem. 2010;109(5):1033–1044. doi:10.1002/jcb.22486
   PubMed Web of Science ®Google Scholar
• Wang X, Li G, Guo C, et al. Ethyl 2-[2,3,4-Trimethoxy-6-(1-Octanoyl)Phenyl] Acetate (TMPA) Ameliorates Lipid Accumulation by Disturbing the Combination of LKB1 with Nur77 and Activating the AMPK Pathway in HepG2 Cells and Mice Primary Hepatocytes. Diabetes Metab Syndr Obes. 2021;14:4165–4177. doi:10.2147/dmso.S321246
   PubMed Web of Science ®Google Scholar
• Sakurai Y, Kubota N, Yamauchi T, Kadowaki T. Role of Insulin Resistance in MAFLD. Int J Mol Sci. 2021;22(8). doi:10.3390/ijms22084156
   Web of Science ®Google Scholar
• Reddy D, Kumavath R, Ghosh P, Barh D. Lanatoside C Induces G2/M Cell Cycle Arrest and Suppresses Cancer Cell Growth by Attenuating MAPK, Wnt, JAK-STAT, and PI3K/AKT/mTOR Signaling Pathways. Biomolecules. 2019;9(12). doi:10.3390/biom9120792
   Web of Science ®Google Scholar
• Liu S, Xu X, Fang Z, et al. Piezo1 impairs hepatocellular tumor growth via deregulation of the MAPK-mediated YAP signaling pathway. Cell Calcium. 2021;95:102367. doi:10.1016/j.ceca.2021.102367
   PubMed Web of Science ®Google Scholar
• Ke R, Xu Q, Li C, Luo L, Huang D. Mechanisms of AMPK in the maintenance of ATP balance during energy metabolism. Cell Biol Int. 2018;42(4):384–392. doi:10.1002/cbin.10915
   PubMed Web of Science ®Google Scholar
• Green MF, Anderson KA, Means AR. Characterization of the CaMKKβ-AMPK signaling complex. Cell Signal. 2011;23(12):2005–2012. doi:10.1016/j.cellsig.2011.07.014
   PubMed Web of Science ®Google Scholar
• Suter M, Riek U, Tuerk R, Schlattner U, Wallimann T, Neumann D. Dissecting the role of 5’-AMP for allosteric stimulation, activation, and deactivation of AMP-activated protein kinase. J Biol Chem. 2006;281(43):32207–32216. doi:10.1074/jbc.M606357200
   PubMed Web of Science ®Google Scholar
• Zhu R, Liu H, Liu C, et al. Cinnamaldehyde in diabetes: a review of pharmacology, pharmacokinetics and safety. Pharmacol Res. 2017;122:78–89. doi:10.1016/j.phrs.2017.05.019
   PubMed Web of Science ®Google Scholar
• Parks EJ, Hellerstein MK. Thematic review series: patient-oriented research. Recent advances in liver triacylglycerol and fatty acid metabolism using stable isotope labeling techniques. J Lipid Res. 2006;47(8):1651–1660. doi:10.1194/jlr.R600018-JLR200
   PubMed Web of Science ®Google Scholar